Skip to content

Surgical trial in lobar intracerebral haemorrhage

Surgical Trial in Lobar Intracerebral Haemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN22153967
Enrollment
600
Registered
2006-10-11
Start date
2007-01-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spontaneous intracerebral haemorrhage confined to the lobar region Circulatory System Intracerebral haemorrhage

Interventions

The trial intervention is early evacuation of the haematoma by craniotomy, combined with appropriate best medical treatment versus best medical treatment, combined with delayed evacuation only if it b

Sponsors

Newcastle upon Tyne Hospitals NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Evidence of a spontaneous lobar ICH on Computed Tomography (CT) scan (within 1 cm of the cortical surface) 2. Patient within 48 hours of ictus 3. The 'clinical uncertainty principle' is used: only patients for whom the responsible neurosurgeon is uncertain about the benefits of either treatment are eligible. These include patients with a haematoma volume of between 10 and 100 ml and a best motor score on the Glasgow Coma Score (GCS) of five or six together with some eye opening

Exclusion criteria

Exclusion criteria: 1. Clear evidence that the haemorrhage is due to an aneurysm or angiographically proven arteriovenous malformation 2. Intraventricular haemorrhage of any sort 3. ICH secondary to tumour or trauma 4. Basal ganglia, thalamic, cerebellar or brainstem haemorrhage or extension of a lobar haemorrhage into any of these regions 5. Severe pre-existing physical or mental disability or severe co-morbidity which might interfere with assessment of outcome 6. If surgery cannot be performed within 12 hours

Design outcomes

Primary

MeasureTime frame
Unfavourable outcome will be death or severe disability, which will be defined using a prognosis-based eight-point Glasgow Outcome Scale/Modified Rankin Scale (Mendelow et al., 2003, 2005)

Secondary

MeasureTime frame
1. Mortality 2. Modified Rankin Scale 3. Barthel's Index of Activities of daily living (BAI) 4. EuroQol Quality of Life Health Survey 5. Survival

Countries

Armenia, Australia, China, Czech Republic, Egypt, England, Germany, Greece, Hungary, India, Italy, Japan, Latvia, Lithuania, Macedonia, Malaysia, Mexico, Nepal, Pakistan, Poland, Romania, Russian Federation, Singapore, Spain, Sri Lanka, Turkey, United Kingdom, United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 29, 2026